Results

Total Results: 884 records

Showing results for "end stage renal".

81. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/49534/psn-pdf
    May 01, 2007 - A different equation is used to correct phenytoin levels for end-stage renal disease, another common … unbound phenytoin monitoring would be to require that it be reported in patients with hypoalbuminemia or end-stage … In patients with low serum albumin or end-stage renal disease, total (bound + unbound) phenytoin levels … Factors That Can Alter Phenytoin Protein Binding (4) Hypoalbuminemia End-stage renal disease (creatinine … Correcting a Total (Bound + Unbound) Phenytoin Level for Hypoalbuminemia and End-Stage Renal Disease

82. Diabetes | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/nhqrdr/chartbooks/effectivetreatment/diabetes.html
    June 01, 2018 - New cases of end stage renal disease due to diabetes. … End Stage Renal Disease Due to Diabetes New cases of end stage renal disease due to diabetes per million … Renal Data System, 2003-2013. Denominator: U.S. resident population. … detected early, medication can slow the disease’s progress; when detected late, it commonly progresses to end … stage renal disease (ESRD) requiring dialysis or kidney transplantation.

83. Statement of The Hospital & Healthsystem Association of Pennsylvania. | PSNet
    psnet.ahrq.gov/issue/statement-hospital-healthsystem-association-pennsylvania
    January 08, 2020 - May 1, 2015 Stories from the sharp end: case studies in safety improvement. … March 19, 2014 Hearing on Patient Safety and Quality Issues in End Stage Renal Disease

84. Failure to Reevaluate | PSNet
    psnet.ahrq.gov/web-mm/failure-reevaluate
    February 01, 2014 - As a result of her renal failure, the patient rapidly developed non-anion gap metabolic acidosis and, … Urine and blood studies failed to identify a clear cause of her renal failure. … Scr is commonly measured to assess renal function but may vary with a variety of renal and nonrenal factors … such as age, gender, weight, muscle metabolism, and protein intake.( 4 ) Specifically, patients with end-stage … Scr may not reflect renal function in patients with reduced muscle mass, malnutrition, and end-stage

85. A demonstration project on the impact of safety culture on infection control practices in hemodialysis | PSNet
    psnet.ahrq.gov/issue/demonstration-project-impact-safety-culture-infection-control-practices-hemodialysis
    May 01, 2024 - January 2, 2017 Medication dosing errors for patients with renal insufficiency in ambulatory … January 2, 2017 AHRQ Safety Program for End-Stage Renal Disease Facilities—Toolkit.

86. Brown, Jeremiah | Agency for Healthcare Research and Quality
    www.ahrq.gov/funding/training-grants/grants/active/kawards/kawdsumbrown.html
    October 01, 2014 - Evaluate whether CI-AKI is associated with the development of CKD, progression of CKD, development of end-stage … renal disease, repeat revascularization, and long-term mortality.

87. A Safer Place for Patients: Learning to Improve Patient Safety. | PSNet
    psnet.ahrq.gov/issue/safer-place-patients-learning-improve-patient-safety-0
    June 22, 2016 - February 19, 2020 Hearing on Patient Safety and Quality Issues in End Stage Renal Disease … January 29, 2015 High Quality Care for All: NHS Next Stage Review Final Report.

88. Antiseizure Medication Disorder | PSNet
    psnet.ahrq.gov/web-mm/antiseizure-medication-disorder
    April 01, 2006 - A different equation is used to correct phenytoin levels for end-stage renal disease, another common … unbound phenytoin monitoring would be to require that it be reported in patients with hypoalbuminemia or end-stage … In patients with low serum albumin or end-stage renal disease, total (bound + unbound) phenytoin levels … Factors That Can Alter Phenytoin Protein Binding ( 4 ) Hypoalbuminemia End-stage renal … Correcting a Total (Bound + Unbound) Phenytoin Level for Hypoalbuminemia and End-Stage Renal Disease

89. Direct Oral Anticoagulants are High-Risk Medications with Potentially Complex Dosing | PSNet
    psnet.ahrq.gov/web-mm/direct-oral-anticoagulants-are-high-risk-medications-potentially-complex-dosing
    August 21, 2005 - reported taking 15 mg twice daily for 19 days (as prescribed) and then took 20 mg twice daily from the end … Stage Renal Disease (ESRD) is limited.  … Safety and efficacy of apixaban in patients with end-stage renal disease: Meta-Analysis. … Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on … WebM&M Cases Overdose of Gabapentin and Oxycodone in a Patient with End-Stage

90. Kidney-Disease-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
    October 01, 2012 - =Congestive Heart Failure; CKD=Chronic Kidney Disease; eGFR=Epidermal growth factor receptor; ESRD=End-Stage … The primary composite end point occurred in 26 patients in the sulodexide group and 30 patients in … 1 or 2 eGFR Indices of kidney injury 30 days Indices of kidney injury were not changed in Stage 1 … However, stage 2 patients decreased urinary albumin, N-acetyl B-D- glucosaminidase and transforming … =Congestive Heart Failure; CKD=Chronic Kidney Disease; eGFR=Epidermal growth factor receptor; ESRD=End-Stage

91. Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
    August 01, 2012 - Evidence that screening is ineffective The draft CER focuses on endpoints for end-stage renal disease … Chronic Kidney Disease‖ American Journal of Medicine (2007) 120, 280.e1-280.e7 (4) Incidence of End-Stage … Minority populations with CKD have more rapid progression to end-stage renal disease (ESRD), which results … ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop; a post … The draft CER focuses on endpoints for end-stage renal disease (ESRD), cardiovascular disease (CVD)

92. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/60611/psn-pdf
    June 24, 2020 - reported taking 15 mg twice daily for 19 days (as prescribed) and then took 20 mg twice daily from the end … Stage Renal Disease (ESRD) is limited.  … daily or 2.5 mg twice daily).12,13 A meta-analysis has shown that use of apixaban in patients with stage … Safety and efficacy of apixaban in patients with end-stage renal disease: Meta-Analysis. … Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease

93. Optimal Diabetes Care (pdf file)
    integrationacademy.ahrq.gov/sites/default/files/2020-07/Optimal_Diabetes_Care.pdf
    January 01, 2020 - developing cardiovascular disease and stroke, non‐traumatic lower extremity amputations, blindness, and end‐stage … renal disease. … Exclusions  Patient was in hospice at any time during the measurement period  Patient died prior to the end … UNSPF NT ST UNCNTRL 250.41 DMI RENL NT ST UNCNTRLD 250.91 DMI UNSPF NT ST UNCNTRLD 250.42 DMII RENAL … UNCNTRLD 250.92 DMII UNSPF UNCNTRLD 250.43 DMI RENAL UNCNTRLD 250.93 DMI UNSPF UNCNTRLD Email: support

94. Part 3: National Quality Strategy Priority—Effective Treatment | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/part3-nqs5.html
    June 01, 2018 - Nephrologist Visit Before Renal Replacement Therapy Patients who saw a nephrologist at least 12 months … prior to initiation of renal replacement therapy, by race 2005-2012 Race 2005 2006 2007 … Renal Data System, 2005-2012. http://www.usrds.org/2014/view/v2_02.aspx . … Groups With Disparities: From 2009 to 2012, the percentage of end stage renal disease (ESRD) patients … who began nephrology care at least 12 months prior to initiation of renal replacement therapy was higher

95. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0398_06-17-2008.pdf
    January 01, 2008 - Topic Selection Process & Next Steps  Biomarkers to guide treatment for iron-deficiency anemia in renal … Biomarkers to Guide Treatment for Iron-Deficiency Anemia in Renal Dialysis Patients Nomination Summary … )  Anemia in patients with end-stage renal disease (ESRD) is a risk factor for increased mortality

96. Acute Renal Failure Hospitalizations, 2005-2014 (pdf file)
    hcup-us.ahrq.gov/reports/statbriefs/sb231-Acute-Renal-Failure-Hospitalizations.pdf
    December 01, 2016 - Acute Renal Failure Hospitalizations, 2005-2014 1 November 2017 Acute Renal Failure … health-related quality of life, increased incidence of chronic kidney disease, accelerated progression to end-stage … For 504,600 stays with any mention of acute renal failure, acute renal failure appeared as the most … failure with lesion of renal cortical necrosis), 584.7 (acute renal failure with lesion of renal medullary … Medicare covers costs for end stage renal disease for patients of all ages, but acute kidney disease

97. Henry Ford Hospital Unit Lowers C. diff Infections by 90 Percent Using AHRQ Safety Program | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/newsroom/case-studies/202501.html
    June 01, 2025 - Those with end-stage renal disease are twice as likely to develop C. diff than other patients. … Within the first year, the hospital-onset C. diff rate dropped by about 70 percent; by the end of 2024

98. Patient Safety in Dialysis Access. | PSNet
    psnet.ahrq.gov/issue/patient-safety-dialysis-access
    September 29, 2017 - This publication raises awareness of safety in end-stage renal disease care, explores factors specific

99. Fair and Reliable Medical Justice Act. | PSNet
    psnet.ahrq.gov/issue/fair-and-reliable-medical-justice-act
    March 06, 2005 - October 31, 2012 Hearing on Patient Safety and Quality Issues in End Stage Renal Disease

100. Patient Safety Improvement Act of 2020. | PSNet
     psnet.ahrq.gov/issue/patient-safety-improvement-act-2020
     February 12, 2020 - October 3, 2017 Hearing on Patient Safety and Quality Issues in End Stage Renal Disease